Isomorphic Labs
To add a bio or update company history, please click update information.
News from Isomorphic Labs
Isomorphic Labs
11 May 2026
Isomorphic Labs raises £1.5bn Series B led by Thrive Capital for AI models that design new drug candidates
Isomorphic Labs develops AI models for drug discovery and drug design across multiple therapeutic areas and drug types. IsoDDE helps researchers predict biological systems and identify potential drug candidates for pharmaceutical development.
Isomorphic Labs
31 Mar 2025
Isomorphic Labs raises over £450m in Series A funding led by Thrive Capital to scale AI drug design and clinical programmes
Isomorphic Labs applies advanced AI models to drug discovery, accelerating the design of new medicines across multiple therapeutic areas and partnering with global pharmaceutical companies.
Isomorphic Labs
- Life Sciences
- London, United Kingdom
- £1.9b
- isomorphiclabs.com
- Update Information
More venture news
- 28 May 2026
PercepticPerceptic raises a £9m seed round led by Accel to unify drug discovery and development on a single AI platform
SeedLife Sciences - 21 May 2026
ImperagenImperagen secures a £5m seed round led by PXN Ventures to accelerate the process of enzyme engineering
SeedLife Sciences - 12 May 2026
Infex TherapeuticInfex Therapeutics secures £4.3m in funding led by Jon Moulton for antimicrobial resistance treatments
EquityLife Sciences
